Judy Lieberman

This inventor holds 21 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Cancer Therapeutics. Top assignees: Children's Medical Center Corporation, Immune Disease Institute, Inc., Harvard College. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judy Lieberman. Retrieved from https://idiyas.com/inventor/judy-lieberman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 10)

% Patents Active = 90.5

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

15 out of 1,074

Children's Medical Center Corporation

patents

4 out of 12

Immune Disease Institute, Inc.

Center for Blood Research, Inc.

patents

5. 1 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

6. 1 out of 64

Rosetta Genomics Ltd.

patents

7. 1 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Inflammation Inhibition

Oligonucleotide Delivery

Cancer Treatment

siRNA Microbicides

Tumor-Initiating Cells

miRNA Targets

RNA Interference

Hematopoietic Malignancies

Retrovirus Inhibition

Metabolite Screening

Gene Expression

Therapeutic Strategies

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714716 - Compounds for inhibition of inflammation (2026-08-25),

2. 12590311 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER (2026-03-31),

3. 11384356 - Composition and method for oligonucleotide delivery (2022-07-12),

4. 11242553 - MiRNA targets (2022-02-08),

5. 11180762 - Methods and compositions for the treatment of cancer (2021-11-23),

6. 11147828 - Let-7 microRNA and mimetics thereof as therapeutics for cancer (2021-10-19),

7. 10508276 - Methods and compositions for the production of siRNAs (2019-12-17),

8. 10435756 - Selective inhibitors of tumor-initiating cells (2019-10-08),

9. 10385343 - Methods and compositions for the treatment of cancer (2019-08-20),

10. 10378016 - Composition and method for oligonucleotide delivery (2019-08-13),

11. 9840703 - Methods and compositions for the production of siRNAs (2017-12-12),

12. 9689040 - Selective inhibitors of tumor-initiating cells (2017-06-27),

13. 9606106 - NMR-based metabolite screening platform (2017-03-28),

14. 9347089 - Therapeutic and diagnostic strategies (2016-05-24),

15. 8927510 - Compositions and methods for inhibition of retroviruses (2015-01-06),

Title: Judy Lieberman - Pioneering Inventor from Brookline, MA

Introduction: Judy Lieberman is a renowned inventor hailing from Brookline, Massachusetts. She has made significant contributions to the field of biotechnology and medical research through her innovative work.

Latest Patents: Judy Lieberman holds several patents related to novel drug delivery systems and gene therapy techniques that have the potential to revolutionize the treatment of various diseases.

Career Highlights: With a background in molecular biology and immunology, Judy Lieberman has dedicated her career to developing cutting-edge technologies aimed at improving healthcare outcomes. Her research has led to the development of groundbreaking therapies for conditions such as cancer and genetic disorders.

Collaborations: Throughout her career, Judy Lieberman has collaborated with leading scientists, researchers, and pharmaceutical companies to further the development and commercialization of her inventions. Her collaborative efforts have resulted in the successful translation of her research from the lab to clinical applications.

Conclusion: Judy Lieberman's passion for innovation and commitment to improving human health have established her as a trailblazer in the field of biotechnology. Her pioneering work continues to inspire the next generation of inventors and researchers in the quest for transformative medical solutions.

Profile summary based on public USPTO records.